ID   NR1D2_RAT               Reviewed;         578 AA.
AC   Q63504; Q62756; Q63542;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=Nuclear receptor subfamily 1 group D member 2 {ECO:0000305};
DE   AltName: Full=EAR4;
DE   AltName: Full=Rev-erb-beta;
GN   Name=Nr1d2 {ECO:0000312|RGD:628828};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8747539;
RA   Giambiagi N., Cassia R., Petropoulos I., Part D., Cereghini S., Zakin M.M.,
RA   Ochoa A.;
RT   "Rev-erb beta 2, a novel isoform of the Rev-erb family of orphan nuclear
RT   receptors.";
RL   Biochem. Mol. Biol. Int. 37:1091-1102(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-578.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7945391; DOI=10.1006/bbrc.1994.2424;
RA   Enmark E., Kainu T., Pelto-Huikko M., Gustafsson J.-A.;
RT   "Identification of a novel member of the nuclear receptor superfamily which
RT   is closely related to Rev-ErbA.";
RL   Biochem. Biophys. Res. Commun. 204:49-56(1994).
CC   -!- FUNCTION: Transcriptional repressor which coordinates circadian rhythm
CC       and metabolic pathways in a heme-dependent manner. Integral component
CC       of the complex transcription machinery that governs circadian
CC       rhythmicity and forms a critical negative limb of the circadian clock
CC       by directly repressing the expression of core clock components BMAL1
CC       and CLOCK. Also regulates genes involved in metabolic functions,
CC       including lipid metabolism and the inflammatory response. Acts as a
CC       receptor for heme which stimulates its interaction with the NCOR1/HDAC3
CC       corepressor complex, enhancing transcriptional repression. Recognizes
CC       two classes of DNA response elements within the promoter of its target
CC       genes and can bind to DNA as either monomers or homodimers, depending
CC       on the nature of the response element. Binds as a monomer to a response
CC       element composed of the consensus half-site motif 5'-[A/G]GGTCA-3'
CC       preceded by an A/T-rich 5' sequence (RevRE), or as a homodimer to a
CC       direct repeat of the core motif spaced by two nuclegotides (RevDR-2).
CC       Acts as a potent competitive repressor of ROR alpha (RORA) function and
CC       also negatively regulates the expression of NR1D1. Regulates lipid and
CC       energy homeostasis in the skeletal muscle via repression of genes
CC       involved in lipid metabolism and myogenesis including: CD36, FABP3,
CC       FABP4, UCP3, SCD1 and MSTN. Regulates hepatic lipid metabolism via the
CC       repression of APOC3. Represses gene expression at a distance in
CC       macrophages by inhibiting the transcription of enhancer-derived RNAs
CC       (eRNAs). In addition to its activity as a repressor, can also act as a
CC       transcriptional activator. Acts as a transcriptional activator of the
CC       sterol regulatory element-binding protein 1 (SREBF1) and the
CC       inflammatory mediator interleukin-6 (IL6) in the skeletal muscle (By
CC       similarity). Plays a role in the regulation of circadian sleep/wake
CC       cycle; essential for maintaining wakefulness during the dark phase or
CC       active period (By similarity). Key regulator of skeletal muscle
CC       mitochondrial function; negatively regulates the skeletal muscle
CC       expression of core clock genes and genes involved in mitochondrial
CC       biogenesis, fatty acid beta-oxidation and lipid metabolism (By
CC       similarity). May play a role in the circadian control of neutrophilic
CC       inflammation in the lung (By similarity).
CC       {ECO:0000250|UniProtKB:Q60674}.
CC   -!- ACTIVITY REGULATION: The heme-bound form can bind gaseous signaling
CC       molecules such as CO and nitric oxide (NO) and NO can reverse its
CC       transcriptional repressor activity. {ECO:0000250}.
CC   -!- SUBUNIT: Binds DNA as a monomer or a homodimer (By similarity).
CC       Interacts with NCOA5 coactivator, leading to a strong increase of
CC       transcription of target genes (By similarity). Interacts (via N-
CC       terminus) with KAT5 (By similarity). Interacts (via C-terminus) with
CC       HDAC1 (By similarity). Interacts with ZNHIT1 (By similarity). Interacts
CC       with SIAH2 (By similarity). {ECO:0000250|UniProtKB:Q14995}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q60674}. Note=Phosphorylation by
CC       CSNK1E enhances its cytoplasmic localization.
CC       {ECO:0000250|UniProtKB:Q60674}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Rev-erb-beta-1;
CC         IsoId=Q63504-1; Sequence=Displayed;
CC       Name=Rev-erb-beta-2;
CC         IsoId=Q63504-2; Sequence=VSP_003650, VSP_003651;
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Deacetylated by HDAC1 (By similarity). Acetylation and
CC       deacetylation regulate its transcriptional regulatory activity (By
CC       similarity). {ECO:0000250|UniProtKB:Q14995}.
CC   -!- PTM: Under more reducing intracellular redox conditions, Cys-383 is in
CC       its heme-bound state, which is optimal for recruitment of the
CC       NCOR1/HDAC3 corepressor complex and repression of target genes (By
CC       similarity). When subjected to oxidative stress conditions, Cys-383
CC       undergoes oxidation to form a disulfide bridge with Cys-373, also
CC       triggering a ligand switch that results in release of bound heme and
CC       derepression of target genes (By similarity).
CC       {ECO:0000250|UniProtKB:Q14995}.
CC   -!- PTM: Ubiquitinated by SIAH2; leading to its proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q14995}.
CC   -!- PTM: Phosphorylated by CSNK1E; phosphorylation enhances its cytoplasmic
CC       localization. {ECO:0000250|UniProtKB:Q60674}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X82777; CAA58021.1; -; mRNA.
DR   EMBL; X78135; CAA55014.1; -; mRNA.
DR   EMBL; U20796; AAA62508.1; -; mRNA.
DR   PIR; S52913; S52913.
DR   RefSeq; NP_671743.2; NM_147210.2. [Q63504-1]
DR   AlphaFoldDB; Q63504; -.
DR   SMR; Q63504; -.
DR   STRING; 10116.ENSRNOP00000075553; -.
DR   PhosphoSitePlus; Q63504; -.
DR   PaxDb; 10116-ENSRNOP00000065585; -.
DR   Ensembl; ENSRNOT00000081845.2; ENSRNOP00000075553.1; ENSRNOG00000046912.3. [Q63504-1]
DR   Ensembl; ENSRNOT00055024135; ENSRNOP00055019695; ENSRNOG00055014018. [Q63504-1]
DR   Ensembl; ENSRNOT00060019087; ENSRNOP00060014909; ENSRNOG00060011268. [Q63504-1]
DR   Ensembl; ENSRNOT00065018213; ENSRNOP00065013896; ENSRNOG00065011229. [Q63504-1]
DR   GeneID; 259241; -.
DR   KEGG; rno:259241; -.
DR   AGR; RGD:628828; -.
DR   CTD; 9975; -.
DR   RGD; 628828; Nr1d2.
DR   eggNOG; KOG4846; Eukaryota.
DR   GeneTree; ENSGT00940000155168; -.
DR   HOGENOM; CLU_007368_2_4_1; -.
DR   InParanoid; Q63504; -.
DR   OrthoDB; 3475284at2759; -.
DR   PhylomeDB; Q63504; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   PRO; PR:Q63504; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000046912; Expressed in skeletal muscle tissue and 20 other cell types or tissues.
DR   ExpressionAtlas; Q63504; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0048512; P:circadian behavior; ISS:UniProtKB.
DR   GO; GO:0097009; P:energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0055088; P:lipid homeostasis; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:2001014; P:regulation of skeletal muscle cell differentiation; ISS:UniProtKB.
DR   CDD; cd07166; NR_DBD_REV_ERB; 1.
DR   CDD; cd06940; NR_LBD_REV_ERB; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050234; Nuclear_hormone_rcpt_NR1.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24082; NUCLEAR HORMONE RECEPTOR; 1.
DR   PANTHER; PTHR24082:SF112; NUCLEAR RECEPTOR SUBFAMILY 1 GROUP D MEMBER 2; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Alternative splicing; Biological rhythms;
KW   Cytoplasm; Disulfide bond; DNA-binding; Heme; Iron; Metal-binding; Nucleus;
KW   Phosphoprotein; Receptor; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..578
FT                   /note="Nuclear receptor subfamily 1 group D member 2"
FT                   /id="PRO_0000053503"
FT   DOMAIN          368..578
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        100..176
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         103..123
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         140..164
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..99
FT                   /note="Modulating"
FT   REGION          1..60
FT                   /note="Required for phosphorylation by CSNK1E and
FT                   cytoplasmic localization"
FT                   /evidence="ECO:0000250|UniProtKB:Q60674"
FT   REGION          13..89
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          214..247
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          396..578
FT                   /note="Interaction with ZNHIT1"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        13..65
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         383
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /evidence="ECO:0000250"
FT   BINDING         567
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         46
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         162
FT                   /note="N6-acetyllysine; by KAT5"
FT                   /evidence="ECO:0000250|UniProtKB:Q14995"
FT   MOD_RES         163
FT                   /note="N6-acetyllysine; by KAT5"
FT                   /evidence="ECO:0000250|UniProtKB:Q14995"
FT   DISULFID        336..342
FT                   /evidence="ECO:0000250"
FT   DISULFID        373..383
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         383
FT                   /note="C -> Q (in isoform Rev-erb-beta-2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003650"
FT   VAR_SEQ         384..578
FT                   /note="Missing (in isoform Rev-erb-beta-2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003651"
FT   CONFLICT        46
FT                   /note="S -> R (in Ref. 2; AAA62508)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   578 AA;  64192 MW;  E2E5370D1617AB35 CRC64;
     MELNAGGVIA YISSSSSASS PASCHSEGSE NSFQSSSSSV PSSPNSSNCD ANGNPKNTDV
     SSIDGVLKSD RTDCPVKTGK PGAPGMTKSH SGMTKFSGMV LLCKVCGDVA SGFHYGVHAC
     EGCKGFFRRS IQQNIQYKKC LKNENCSIMR MNRNRCQQCR FKKCLSVGMS RDAVRFGRIP
     KREKQRMLIE MQSAMKTMMS TQFGGHLQSD TLAEPHEQSV PPAQEQLRPK PQLEQENIKS
     TPPPSDFAKE EVIGMVTRAH KDTFLYNQEH RENSSESMPP HRGERIPRNV EQYNLNHDHR
     GGGLHSHFPC SESQQHLSGQ YKGRNMMHYP NGHTVCISNG HCVNFSSAYP QRVCDRIPVG
     GCSQTESRNS YLCSTGGRMH LVCPMSKSPY VDPQKSGHEI WEEFSMSFTP AVKEVVEFAK
     RIPGFRDLSQ HDQVNLLKAG TFEVLMVRFA SLFDAKERTV TFLSGKKYSV DDLHSMGAGD
     LLSSMFEFSE KLNGLQLSDE EMSLFTAVVL VSADRSGIEN VNSVEALQET LIRALRTLIM
     KNHPNEASIF TKLLLKLPDL RSLNNMHSEE LLAFKVHP
//
